Evidence map›Paper›PMID 24711523›Full record

ArticleHypertension (Dallas, Tex. : 1979)2014

Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.

Zhuo Fu, Lina Zhao, Kevin W Aylor, Robert M Carey, Eugene J Barrett, Zhenqi Liu

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04203927 (Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04203927 early_phase1unknown statusstarted 2020, after this paper: background citation

Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes

Ran2020Enrolled50Registered outcomes4Posted comparisons0ConditionsInsulin Sensitivity, Type2 DiabetesArmsempagliflozin 25 mg
Open the trial in the graph
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity.Clinical science (London, England : 1979) · 2015 · on this map
    Article
  17. Article
  18. Vascular function, insulin action, and exercise: an intricate interplay.Trends in endocrinology and metabolism: TEM · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhuo FuDivision of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, PO Box 801410, Charlottesville, VA 22908. zl3e@virginia.edu.
Lina Zhao
Kevin W Aylor
Robert M Carey
Eugene J Barrett
Zhenqi Liu
University of Virginia Health System · US

Funding

Research Training in Neuroendocrinology and MetabolismT32DK007646 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ZHENQI LIU · 1990 to 2026
$4.9M
Insulin action in human cardiac and skeletal muscle microvasculatureR01HL094722 · NHLBI · UNIVERSITY OF VIRGINIA · PI LIU, ZHENQI · 2010 to 2014
$1.9M
NHLBI NIH HHS R01 HL094722NHLBI NIH HHS R01HL094722NIDDK NIH HHS 1-T32-DK07646NIDDK NIH HHS T32 DK007646
6 · The paper itself

Abstract

Angiotensin-(1-7) [Ang-(1-7)], an endogenous ligand for the G protein-coupled receptor Mas, exerts both vasodilatory and insulin-sensitizing effects. In skeletal muscle, relaxation of precapillary arterioles recruits microvasculature and increases the endothelial surface area available for nutrient and hormone exchanges. To assess whether Ang-(1-7) recruits microvasculature and enhances insulin action in muscle, overnight-fasted adult rats received an intravenous infusion of Ang-(1-7) (0, 10, or 100 ng/kg per minute) for 150 minutes with or without a simultaneous infusion of the Mas inhibitor A-779 and a superimposition of a euglycemic insulin clamp (3 mU/kg per minute) from 30 to 150 minutes. Hind limb muscle microvascular blood volume, microvascular flow velocity, and microvascular blood flow were determined. Myographic changes in tension were measured on preconstricted distal saphenous artery. Ang-(1-7) dose-dependently relaxed the saphenous artery (P<0.05) ex vivo. This effect was potentiated by insulin (P<0.01) and abolished by either endothelium denudement or Mas inhibition. Systemic infusion of Ang-(1-7) rapidly increased muscle microvascular blood volume and microvascular blood flow (P<0.05, each) without altering microvascular flow velocity. Insulin infusion alone increased muscle microvascular blood volume by 60% to 70% (P<0.05). Adding insulin to the Ang-(1-7) infusion further increased muscle microvascular blood volume and microvascular blood flow (≈2.5 fold; P<0.01). These were associated with a significant increase in insulin-mediated glucose disposal and muscle protein kinase B and extracellular signal-regulated kinase 1/2 phosphorylation. A-779 pretreatment blunted the microvascular and insulin-sensitizing effects of Ang-(1-7). We conclude that Ang-(1-7) by activating Mas recruits muscle microvasculature and enhances the metabolic action of insulin. These effects may contribute to the cardiovascular protective responses associated with Mas activation and explain the insulin-sensitizing action of Ang-(1-7).

Indexed as

Angiotensin IAngiotensin IIAnimalsArteriesBlood Flow VelocityBlotting, WesternDose-Response Relationship, DrugEndothelium, VascularExtracellular Signal-Regulated MAP KinasesGlucoseHindlimbHypoglycemic AgentsInfusions, IntravenousInsulinIn Vitro TechniquesMale7-Ala-angiotensin (1-7)Angiotensin Iangiotensin I (1-7)Angiotensin IIExtracellular Signal-Regulated MAP KinasesGlucoseHypoglycemic AgentsInsulinPeptide FragmentsProto-Oncogene MasProto-Oncogene ProteinsProto-Oncogene Proteins c-aktReceptors, G-Protein-Coupledangiotensinsendothelial cellsmicrovasculaturemuscles

Identifiers

PMID24711523
PMCPMC4030711
OpenAlexW2126676515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.